ACAA2
Basic information
Region (hg38): 18:49782164-49813953
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ACAA2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 22 | 25 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 1 | |||||
Total | 0 | 0 | 22 | 3 | 1 |
Variants in ACAA2
This is a list of pathogenic ClinVar variants found in the ACAA2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
18-49783909-C-G | not specified | Uncertain significance (Nov 07, 2022) | ||
18-49783909-C-T | not specified | Likely benign (Jun 21, 2022) | ||
18-49783920-C-G | not specified | Uncertain significance (Jan 10, 2023) | ||
18-49783926-C-A | not specified | Uncertain significance (Jul 20, 2021) | ||
18-49783930-G-A | not specified | Uncertain significance (Nov 15, 2023) | ||
18-49785204-C-T | not specified | Uncertain significance (Dec 21, 2022) | ||
18-49785245-A-T | not specified | Uncertain significance (Jul 07, 2022) | ||
18-49787272-A-AC | Likely benign (Dec 30, 2023) | |||
18-49787302-C-A | not specified | Uncertain significance (Apr 01, 2024) | ||
18-49787309-C-G | not specified | Uncertain significance (Apr 28, 2022) | ||
18-49791473-T-C | not specified | Uncertain significance (Jul 14, 2023) | ||
18-49791553-G-C | not specified | Uncertain significance (Sep 17, 2021) | ||
18-49791586-C-T | not specified | Uncertain significance (Mar 19, 2024) | ||
18-49791596-C-T | not specified | Likely benign (Mar 05, 2024) | ||
18-49792157-C-T | not specified | Uncertain significance (May 02, 2024) | ||
18-49792193-C-T | not specified | Uncertain significance (May 04, 2022) | ||
18-49792255-A-G | not specified | Uncertain significance (Sep 22, 2022) | ||
18-49792289-T-C | not specified | Uncertain significance (May 31, 2022) | ||
18-49792313-A-T | Benign (Oct 17, 2017) | |||
18-49794310-C-T | not specified | Uncertain significance (May 31, 2023) | ||
18-49794412-A-G | not specified | Uncertain significance (Mar 17, 2023) | ||
18-49795784-T-G | not specified | Uncertain significance (May 03, 2023) | ||
18-49795809-C-T | not specified | Uncertain significance (Jul 28, 2021) | ||
18-49795814-T-C | not specified | Uncertain significance (Oct 26, 2022) | ||
18-49795868-T-C | not specified | Uncertain significance (Jan 24, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ACAA2 | protein_coding | protein_coding | ENST00000285093 | 10 | 30462 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
3.71e-10 | 0.181 | 125661 | 0 | 87 | 125748 | 0.000346 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.271 | 220 | 209 | 1.05 | 0.0000104 | 2551 |
Missense in Polyphen | 92 | 84.824 | 1.0846 | 988 | ||
Synonymous | 0.897 | 63 | 72.7 | 0.866 | 0.00000375 | 805 |
Loss of Function | 0.559 | 16 | 18.6 | 0.860 | 9.33e-7 | 248 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00227 | 0.00228 |
Ashkenazi Jewish | 0.0000992 | 0.0000992 |
East Asian | 0.000163 | 0.000163 |
Finnish | 0.0000925 | 0.0000924 |
European (Non-Finnish) | 0.000221 | 0.000220 |
Middle Eastern | 0.000163 | 0.000163 |
South Asian | 0.000262 | 0.000261 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Abolishes BNIP3-mediated apoptosis and mitochondrial damage. {ECO:0000269|PubMed:18371312}.;
- Pathway
- Fatty acid degradation - Homo sapiens (human);Fatty acid elongation - Homo sapiens (human);Valine, leucine and isoleucine degradation - Homo sapiens (human);Long chain acyl-CoA dehydrogenase deficiency (LCAD);3-Methylglutaconic Aciduria Type I;Valine, Leucine and Isoleucine Degradation;2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency;Trifunctional protein deficiency;Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD);Carnitine palmitoyl transferase deficiency (II);Very-long-chain acyl coa dehydrogenase deficiency (VLCAD);Medium chain acyl-coa dehydrogenase deficiency (MCAD);Fatty Acid Elongation In Mitochondria;Isovaleric Aciduria;3-Methylcrotonyl Coa Carboxylase Deficiency Type I;Propionic Acidemia;Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency);Fatty acid Metabolism;Maple Syrup Urine Disease;3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency;Isobutyryl-coa dehydrogenase deficiency;3-hydroxyisobutyric aciduria;3-hydroxyisobutyric acid dehydrogenase deficiency;Isovaleric acidemia;Glutaric Aciduria Type I;Ethylmalonic Encephalopathy;Methylmalonate Semialdehyde Dehydrogenase Deficiency;Mitochondrial Beta-Oxidation of Short Chain Saturated Fatty Acids;Mitochondrial Beta-Oxidation of Medium Chain Saturated Fatty Acids;Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids;Short-chain 3-hydroxyacyl-CoA dehydrogenase deficiency (SCHAD);Methylmalonic Aciduria;3-Methylglutaconic Aciduria Type IV;3-Methylglutaconic Aciduria Type III;Beta-Ketothiolase Deficiency;Carnitine palmitoyl transferase deficiency (I);miR-targeted genes in epithelium - TarBase;miR-targeted genes in leukocytes - TarBase;miR-targeted genes in lymphocytes - TarBase;miR-targeted genes in muscle cell - TarBase;miR-targeted genes in squamous cell - TarBase;Fatty Acid Biosynthesis;Liver steatosis AOP;Metabolism of lipids;Mitochondrial Fatty Acid Beta-Oxidation;3-oxo-10R-octadecatrienoate beta-oxidation;Leukotriene metabolism;Saturated fatty acids beta-oxidation;Metabolism;Fatty acid metabolism;Propanoate metabolism;Mono-unsaturated fatty acid beta-oxidation;Omega-6 fatty acid metabolism;Valine, leucine and isoleucine degradation;Dimethyl-branched-chain fatty acid mitochondrial beta-oxidation;Di-unsaturated fatty acid beta-oxidation;Vitamin E metabolism;fatty acid β-oxidation (peroxisome);fatty acid β-oxidation;bile acid biosynthesis, neutral pathway;Valine Leucine Isoleucine degradation
(Consensus)
Recessive Scores
- pRec
- 0.366
Intolerance Scores
- loftool
- 0.307
- rvis_EVS
- -0.58
- rvis_percentile_EVS
- 18.72
Haploinsufficiency Scores
- pHI
- 0.175
- hipred
- N
- hipred_score
- 0.319
- ghis
- 0.543
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.0135
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Acaa2
- Phenotype
Gene ontology
- Biological process
- fatty acid beta-oxidation;cholesterol biosynthetic process;cellular response to hypoxia;negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway;negative regulation of mitochondrial membrane permeability involved in apoptotic process
- Cellular component
- mitochondrion;mitochondrial matrix
- Molecular function
- RNA binding;acetyl-CoA C-acetyltransferase activity;acetyl-CoA C-acyltransferase activity;protein binding